Skip to content

ADPT

Adaptive Biotechnologies Corporation

NASDAQ · USHealthcareBiotechnology
$21.86-4.62%

Price as of Jul 20, 2026

ADPT capital

Adaptive Biotechnologies Corporation capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.96x
Net debt / equity
0.60x
Debt / assets
0.41x
Debt / EBITDA
-9.45x
Net debt / EBITDA
-5.93x

Liquidity & coverage

Current ratio
3.35x
Quick ratio
3.22x
Cash ratio
2.51x
Interest coverage
-3.97x
EBITDA / interest
-1.87x
Working capital
$204.8M

Cash & dividend

FCF / debt
-0.14x
Cash flow / debt
-0.13x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.